Medios AG

XETRA ILM1.DE

Medios AG Return on Assets (ROA) for the year ending December 31, 2023: 3.16%

Medios AG Return on Assets (ROA) is 3.16% for the year ending December 31, 2023, a -0.62% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Medios AG Return on Assets (ROA) for the year ending December 31, 2022 was 3.18%, a 125.34% change year over year.
Medios AG Return on Assets (ROA) for the year ending December 31, 2021 was 1.41%, a -50.28% change year over year.
Medios AG Return on Assets (ROA) for the year ending December 31, 2020 was 2.84%, a -66.08% change year over year.
Medios AG Return on Assets (ROA) for the year ending December 31, 2019 was 8.37%, a 90.44% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

XETRA: ILM1.DE

Medios AG

CEO	Mr. Matthias Gaertner
IPO Date	Dec. 28, 2007
Location	Germany
Headquarters	Heidestrasse 9
Employees	1,011
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Retail & Wholesale Specialty Retail

Description

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Key trends

Past 5 years